Amolyt Pharma

Developer of peptide therapeutics to treat rare endocrine and metabolic disorders

placeEcully, Auvergne Rhone Alpes, France calendar_todayFounded 2015 groups6 employees language amolytpharma.com

Registered entities

Investor mix

25 investors on record; lead investors include Sectoral, Andera Partners, Life Sciences Partners, Sofinnova Partners; 7 have since exited.

Investor typeCountShare
Venture capital936%
Private equity728%
Bank & private debt28%
Other / undisclosed728%
Coming soon